Xavier Buy is an expert in Medical imaging at Institut Bergonié (France). Xavier Buy has authored 130 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 2 of them ongoing. SLR score: 333 (community average: 125). How the SLR is computed.

LeadR Profile

Xavier Buy Institut Bergonié France
333 ScienceLeadR Reputation 333
Network Map

Medical imaging

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2006 - 2026

Source: PubMed

Institut Bergonié

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 130

Citations

Citations: 4 294 1st author: 10 Last author: 9 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Curative-Intent Cryoablation for Bone Metastases: Study Protocol for BOREALIS, a Prospective Multicentre Observational Investigation.
PMID 42618654 — quality of life, pain, radiography, cryosurgery, neoplasm metastasis, radionuclide imaging
Cardiovasc Intervent Radiol20261
Corrigendum to 'Impact on survival without chemotherapy of local treatments of lung metastasis of colorectal cancers: Analysis on REPULCO cohort' [Digestive and Liver Disease 56 (2024) 1930-7].
PMID 40877066 — liver diseases, lung, drug therapy, liver, neoplasm metastasis, therapeutics, colorectal neoplasms, chemotherapy
Dig Liver Dis20250
Impact on survival without chemotherapy of local treatments of lung metastasis of colorectal cancers: Analysis on REPULCO cohort.
PMID 38763795 — digestive system diseases, drug therapy, neoplasm metastasis, therapeutics, colorectal neoplasms, lung, disease-free survival, progression-free survival, chemotherapy
Dig Liver Dis20240
Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study.
PMID 38374062 — sarcoma, cells, therapeutics, neoplasms, t-lymphocytes, cyclophosphamide, disease-free survival, trabectedin, progression-free survival, tumor-associated macrophages
Mol Cancer Top journal20242
Percutaneous tumor ablation versus image guided robotic-assisted partial nephrectomy for cT1b renal cell carcinoma: a comparative matched-pair analysis (UroCCR 80).
PMID 37728492 — cells, urology, hospitalization, neoplasms, nephrectomy, carcinoma, renal cell, morbidity, therapeutics, matched-pair analysis
Minerva Urol Nephrol20234

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 4
Phase 2 1

By status:

Completed 3
Not yet recruiting 1
Recruiting 1

By type:

Interventional 4
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 2
multicentricup10 1

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Performance and Safety of the Innofix Screw (IF25)
NCT06800417 — safety, neoplasms, fractures, spontaneous, pelvic bones
N/ANot yet recruiting2025
BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe
NCT06480955 — registries, cryosurgery, neoplasm metastasis
N/ARecruiting2025

LeadR Networks

Main global connection map